Clinical trial
Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on…
NCT00398333 · Hospital Clinic of Barcelona, Other · Terminated
Key facts
| NCT number | NCT00398333 |
|---|---|
| Title | Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on Chemotherapy Tolerance in Colon Cancer Patients |
| Official title | Randomized Controlled, Open-label, Pilot Study to Assess the Effectiveness of a Nutritional Supplementation Enriched With Eicosapentaenoic Acid on Chemotherapy Tolerance in Patients With Advanced Colorectal Cancer |
| Lead sponsor | Hospital Clinic of Barcelona, Other |
| Collaborators | Abbott Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Colorectal Neoplasms |
| Intervention type | Dietary Supplement |
| Interventions | Eicosapentaenoic acid enriched nutritional supplement |
| Enrollment | 13 |
| Start date | Jun 1, 2005 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Nov 10, 2006 |
| Last update posted | Jun 20, 2013 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: